Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

We identify. We verify. We simplify. From the lab to the line and field, we enable our customers to make the world healthier, cleaner, and safer with world-class Thermo Scientific™ products and ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Mainz Biomed (MYNZ) announced a collaborative agreement with Thermo Fisher Scientific (TMO), through its subsidiary ... Mainz Biomed’s Next Generation colorectal cancer screening product. The ...

Seer (SEER) announced a co-marketing and sales agreement with Thermo Fisher (TMO) to jointly promote Seer’s Proteograph Product Suite ...

We came across a bullish thesis on Thermo Fisher ... range of scientific instruments, equipment, consumables, and services ...

and they were basically flat at its Laboratory and Product Services segment. Thermo Fisher boosted the low end of its full-year adjusted EPS outlook. Shares of Thermo Fisher Scientific (TMO ...

At ASHG, Seer showcased its Proteograph product suite which it claims delivers proteomic ... Seer also announced a ...

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 third quarter conference call. My name is Ezra, and I will be your coordinator today. [Operator instructions] I ...

Laboratory Products and Services: I project the segment will grow by 9%, in line with historical trends. As such, I calculate Thermo Fisher Scientific’s revenue will grow by 9% organically.

The market expects Thermo Fisher Scientific (TMO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2024. This widely-known ...